DrugNews Pradaxa Update: Docs Unsealed in Suit Show Concerns of Drug Maker

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit DrugNews.net or speak with a lawyer about their legal options.

Chicago, IL (PRWEB) February 12, 2014

The prescription drug safety center DrugNews.net is announcing new information on the site for patients taking the blood thinner Pradaxa. A new report over documents unsealed by a federal judge shows the maker of the drug worried an internal study might hurt sales if released*.

DrugNews was created to share the latest recalls, safety alerts, research and litigation news with patients taking popular prescription drugs. Visitors can recognize potential dangers, see if others are experiencing similar side effects and decide if they need legal advice.

Pradaxa is a blood thinner approved by the FDA in 2010 to prevent blood clots and strokes in patients with atrial fibrillation. Experts disagree, however, whether it increases risks of internal bleeding.

DrugNews has added warnings from the Institute for Safe Medication Practices that Pradaxa bleeding may be 5 times as likely to cause death**. A recent study also suggested patients taking newer blood thinners including dabigatran may be 55% more likely to suffer internal bleeding***.

Recently, the FDA announced a new study that will examine internal bleeding and blood clot rates from Pradaxa and warfarin patients to draw a comparison****.

So far, 2,057 families have filed a Pradaxa lawsuit alleging internal bleeding, leading to the consolidation of cases in a special federal Pradaxa multidistrict litigation court*****. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Now, DrugNews has learned that documents unsealed by the judge from manufacturer Boehringer Ingelheim show concern that an internal study suggesting some patients may benefit from regular blood testing to protect from stroke or internal bleeding while on Pradaxa could hurt sales if released*.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit DrugNews.net or speak with a lawyer about their legal options. Due to the specialized nature of federal drug injury cases, DrugNews only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugNews.net today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*New York Times, 2/6/14; nytimes.com/2014/02/06/business/study-of-blood-clot-drug-pradaxa-unnerved-its-maker-documents-suggest.html
**Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
***Gastroenterology, July 2013; gastrojournal.org/article/S0016-5085(13)00290-4/fulltext
****Forbes, 1/3/14; forbes.com/sites/larryhusten/2014/01/03/fda-plans-new-safety-assessment-of-dabigatran-pradaxa/
*****Judicial Panel on Multidistrict Litigation, 1/15/14; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-January-15-2014.pdf


Contact